Ryan Allway June 25th, 2021 Psychedelics TORONTO, June 25, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce... Read more
Ryan Allway June 24th, 2021 Psychedelics MONTEGO BAY, Jamaica, June 24, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“ Silo Wellness ” or the “ Company ”) (CSE: SILO) (OTC: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced the launch of Marley One, the first global functional and psychedelic mushroom consumer brand,... Read more
Ryan Allway June 24th, 2021 Psychedelics VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to announce that... Read more
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave.
June 22, 2021
Ryan Allway June 22nd, 2021 Psychedelics To drive brand awareness of, and access to, HaluGen’s Psychedelics Genetic Test Kit Vancouver, British Columbia–(Newsfile Corp. – June 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines... Read more
Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development
June 17, 2021
Ryan Allway June 17th, 2021 Psychedelics TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (“Psyence” or the “Company”) (PSYG:CSE), a public life science biotechnology company pioneering the use of natural psychedelics, is pleased to announce that through its wholly owned Jamaican subsidiary, Psyence Jamaica Limited (“Psyence Jamaica”), it has entered into... Read more
Ryan Allway June 17th, 2021 Psychedelics Vancouver, British Columbia–(Newsfile Corp. – June 17, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon”), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. (CSE: SILO) (OTC: SILFF) (FSE:3K70) (“Silo Wellness”), a functional and psilocybin mushroom... Read more
Ryan Allway June 16th, 2021 Psychedelics VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce the Company has completed its land survey and soil analysis for cultivation of... Read more
Expanded A.I. and machine learning capabilities will accelerate Mydecine’s broader research and development efforts
June 16, 2021
Ryan Allway June 16th, 2021 Psychedelics DENVER, June 16, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the launch of... Read more
Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies
June 16, 2021
Ryan Allway June 16th, 2021 Psychedelics TORONTO, June 16, 2021 /CNW/ – Wake Network Inc. (“Wake” or the “Company“), a global leader in psilocybin and medicinal mushroom production and developer of genomics-based integration therapies, is pleased to announce that it has entered into an agreement with Santé Cannabis (“Sante”) for consultation and... Read more
Ryan Allway June 16th, 2021 Psychedelics Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – June 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company has entered into... Read more
